Plan to Detect Hemorrhagic Fever Syndrome Causative Pathogens Using Molecular Diagnostics, Led by Korea Disease Control and Prevention Agency
[Asia Economy Reporter Hyungsoo Park] Intronbio announced on the 22nd that it has been selected for the "Development of Genetic Kits to Identify Pathogens Causing Unexplained Hemorrhagic Fever Syndrome," a project led by the Korea Disease Control and Prevention Agency.
The company will develop genetic diagnostic kits targeting more than 26 types of hemorrhagic fever syndrome pathogens occurring worldwide. This project involves developing diagnostic kits using Intronbio's core molecular diagnostic technology.
Hemorrhagic fever syndrome is an infectious disease accompanied by massive bleeding and high fever. It is known as a feared infectious disease among patients due to the visual terror caused by multiple organ bleeding after infection, followed by intense pain in a short time and often resulting in death.
In Korea, epidemic hemorrhagic fever was mostly caused by hantavirus transmitted by rodents in the past, but with globalization and increased population movement, concerns about hemorrhagic fever diseases imported from abroad, such as the African Ebola virus infection epidemic, are growing.
Intronbio sees the need for proactive laboratory testing methods to identify the pathogens causing hemorrhagic fever syndrome and has decided to develop diagnostic techniques and products using molecular diagnostic methods based on real-time genetic amplification technology with high sensitivity and specificity.
An Intronbio official stated, "To detect and diagnose pathogens of unexplained hemorrhagic fever syndrome from acute patients, molecular diagnostic methods that directly detect the infectious agents are effective."
He added, "Through this development project, we will proceed with the development and commercialization of products that quickly screen and identify the causative agents of hemorrhagic fever syndrome," and "We will contribute to establishing reliable testing methods that can respond in quarantine and public health fields."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
